Hypercoagulation in diabetes mellitus.

dc.contributor.authorAcang, Nen_US
dc.contributor.authorJalil, F Den_US
dc.date.accessioned2009-05-27T15:08:41Z
dc.date.available2009-05-27T15:08:41Z
dc.date.issued1993-03-01en_US
dc.descriptionThe Southeast Asian Journal of Tropical Medicine and Public Health.en_US
dc.description.abstractThe pathogenesis of diabetic vascular disease is not completely known. Many authors have suggested that hemorheological disturbance is an important factor in the development of vascular complication. The hypercoagulable state also suggested to cause this complication. In order to assess the role of blood coagulation in diabetic patients, we investigated hypercoagulation in diabetic patients and its relation with duration of the disease, smoking habits, blood pressure, blood glucose, diabetic retinopathy, diabetic ulcers and patient treatment. A case control study was done to evaluate these factors in 60 diabetic patients in out-and in-patient clinics of the Department of Internal Medicine, General Hospital Dr M Jamil Padang, during December 1990-March 1991. The average age was 51.55 years, average duration of the disease 5, 8 years. Fibrinogen levels is higher in diabetic patient (mean +/- SD = 442.42 +/- 86.79 mg/dl), compared to normal person (mean +/- SD = 349.2 +/- 35.26 mg/dl), PT is shorter (mean +/- SD = 10.1 +/- 1.31 sec), compared to normal person (mean +/- SD = 11.04 +/- 0.93 sec), APTT is also shorter (mean +/- SD = 29.2 +/- 3.69 sec), compared to normal person (mean +/- SD = 32.16 +/- 3.77 sec). There was a significantly high fibrinogen and short PT and APTT in diabetic patients, especially those who suffered from diabetes for a long time and followed by chronic complications.en_US
dc.description.affiliationDepartment of Internal Medicine, University of Andalas General Hospital Dr M Jamil Padang, Indonesia.en_US
dc.identifier.citationAcang N, Jalil FD. Hypercoagulation in diabetes mellitus. The Southeast Asian Journal of Tropical Medicine and Public Health. 1993 ; 24 Suppl 1(): 263-6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/32028
dc.language.isoengen_US
dc.source.urihttps://www.tm.mahidol.ac.th/seameo/publication.htmen_US
dc.subject.meshAdulten_US
dc.subject.meshBlood Coagulation Disorders --blooden_US
dc.subject.meshBlood Glucoseen_US
dc.subject.meshCase-Control Studiesen_US
dc.subject.meshDiabetes Complicationsen_US
dc.subject.meshDiabetes Mellitus --blooden_US
dc.subject.meshFemaleen_US
dc.subject.meshFibrinogen --analysisen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPartial Thromboplastin Timeen_US
dc.subject.meshProthrombin Timeen_US
dc.subject.meshRisk Factorsen_US
dc.titleHypercoagulation in diabetes mellitus.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: